Compounds > nevirapine

nevirapine and rolipram

nevirapine has been researched along with rolipram in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Buckheit, RW; Cheung, YF; Cullen, MD; Cushman, M; De Clercq, E; Hartman, TL; Houslay, MD; Pannecouque, C; Watson, KM1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Anaclerio, B; Bieza, K; Caldwell, J; Ellis, D; He, X; He, Y; Karanewsky, D; Kuhen, K; Ngoc Nguyen, T; Wolff, K; Wu, B; Yang, K; Yin, H1

Other Studies

4 other study(ies) available for nevirapine and rolipram

ArticleYear
Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
    Bioorganic & medicinal chemistry letters, 2008, Feb-15, Volume: 18, Issue:4

    Topics: Alkenes; Cell Line, Tumor; Cyclic Nucleotide Phosphodiesterases, Type 4; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Methane; Oxazoles; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2008
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Bioorganic & medicinal chemistry letters, 2006, Jul-01, Volume: 16, Issue:13

    Topics: Anti-HIV Agents; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidinones; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Virus Replication

2006